2023
DOI: 10.1007/978-3-031-37196-7_9
|View full text |Cite
|
Sign up to set email alerts
|

Machine Learning for Protein Engineering

Kadina E. Johnston,
Clara Fannjiang,
Bruce J. Wittmann
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 143 publications
0
12
0
Order By: Relevance
“…ML4-MBO-DNN (Methods) was the strongest-performing member of the portfolio of methods in ML4 in terms of hit rate (see Supplementary Table 1). It had similar size as HR4 (1356 vs. 1540 variants) and significantly outperformed HR4 at finding hits above the A73R level (chi-square test; P=1.3×10 -9 ): 52 ± 7 of the 1356 ML4-MBO-DNN variants (hit-rate 3.9% ± 0.5%; standard deviations estimated via bootstrapping) had greater activity than A73R, compared to only 7 ± 4 of the 1540 HR4 variants (hit-rate 0.5% ± 0.2%). For discovering variants with activity greater than the WT, ML4-MBO-DNN significantly outperformed HR4 (chi-square test; p < 1e-15).…”
Section: Resultsmentioning
confidence: 96%
See 3 more Smart Citations
“…ML4-MBO-DNN (Methods) was the strongest-performing member of the portfolio of methods in ML4 in terms of hit rate (see Supplementary Table 1). It had similar size as HR4 (1356 vs. 1540 variants) and significantly outperformed HR4 at finding hits above the A73R level (chi-square test; P=1.3×10 -9 ): 52 ± 7 of the 1356 ML4-MBO-DNN variants (hit-rate 3.9% ± 0.5%; standard deviations estimated via bootstrapping) had greater activity than A73R, compared to only 7 ± 4 of the 1540 HR4 variants (hit-rate 0.5% ± 0.2%). For discovering variants with activity greater than the WT, ML4-MBO-DNN significantly outperformed HR4 (chi-square test; p < 1e-15).…”
Section: Resultsmentioning
confidence: 96%
“…The ability to engineer proteins has revolutionized applications in industry and therapeutics [1][2][3][4][5][6] . Generally, a protein engineering campaign can be divided into two stages [7][8][9] : discovery first finds a candidate protein that performs a desired function at a non-zero level of activity and then optimization improves its attributes, such as the binding strength of an antibody 10 or the catalytic activity 11 , thermostability 12,13 , or stereoselectivity of an enzyme 14 . Directed evolution (DE) is the standard technique for protein optimization, where a pool of genotypes is iteratively improved using in-vitro selection and mutagenesis [15][16][17][18] .…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Directed evolution (DE) is a conventional approach in protein engineering that aims to search for global maximal protein sequences from a large database of unlabeled candidates S with minimal experimental validation [38], [39]. DE employs an accelerated cycle of mutation and selection, which iteratively generates a pool of protein variants and selects those having improved desired properties as the next generation.…”
Section: A Directed Evolution Theorymentioning
confidence: 99%